These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5611970)

  • 21. [Neutralizing antibodies against rubella in a group of pregnant women in São Paulo].
    Cotillo LG
    Rev Saude Publica; 1968 Jun; 2(1):29-43. PubMed ID: 5740989
    [No Abstract]   [Full Text] [Related]  

  • 22. [Behavior of neutralizing antibodies and complement fixing antibodies against the respiratory syncytial virus in relation to age].
    Pauluzzi S; De Rosa F
    Riv Ist Sieroter Ital; 1969; 44(1):75-85. PubMed ID: 5397605
    [No Abstract]   [Full Text] [Related]  

  • 23. [Epidemiological studies on rubella].
    Archegas Ferreira ME; do Carmo Lagrota MH; de Moraes Andrade C
    Rev Latinoam Microbiol; 1974; 16(3):143-5. PubMed ID: 4530434
    [No Abstract]   [Full Text] [Related]  

  • 24. [Aspects of the rubella epidemic of 1973. Preliminary analysis of the date concerning 29 towns of the Piedmont and Valle D'Aosta regions].
    Moiraghi-Ruggenini A; Macagno F; Secreto R
    Boll Ist Sieroter Milan; 1977 Mar; 56(2):159-63. PubMed ID: 871344
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunologic aspects of congenital rubella.
    Michaels RH
    Pediatrics; 1969 Mar; 43(3):339-50. PubMed ID: 4180266
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavior of hemagglutination-inhibiting and neutralizing antibodies in young patients with rubella].
    Grasso A; Scalise G; Gagnoni G; Lunghetti R
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):1109-17. PubMed ID: 5760320
    [No Abstract]   [Full Text] [Related]  

  • 27. Congenital rubella syndrome. Lymphoid tissue and immunologic status.
    Singer DB; South MA; Montgomery JR; Rawls WE
    Am J Dis Child; 1969 Jul; 118(1):54-61. PubMed ID: 4182943
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rubella. Serological survey in Pelotas, Rio Grande do Sul, Brazil].
    de Mattos IG; de Moraes Andrade C; Vasconcelos Mamfrim AJ; Ferreira ME
    Rev Inst Med Trop Sao Paulo; 1978; 20(2):99-101. PubMed ID: 675034
    [No Abstract]   [Full Text] [Related]  

  • 29. Rubella antibody studies in the inhabitants of Montreal. Incidence of hemagglutination-inhibiting, complement-fixing and neutralizing antibodies.
    Chagnon A; Davignon L; Pavilanis V
    Can J Public Health; 1969 Oct; 60(10):395-401. PubMed ID: 5345621
    [No Abstract]   [Full Text] [Related]  

  • 30. Persistence of rubella antibodies following natural infection.
    Dunlevy M
    J Ir Med Assoc; 1974 Mar; 67(5):127-9. PubMed ID: 4815647
    [No Abstract]   [Full Text] [Related]  

  • 31. The 2001 serological survey in the Czech Republic--rubella.
    Mrázová M; Smelhausová M; Sestáková Z; Svandová E; Benes C
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S42-9. PubMed ID: 15080259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemagglutination-inhibiting antibodies against rubella in childhood].
    Nigro N; Benso L; Rosa Brunet M; Iudicello P
    G Mal Infett Parassit; 1970 Jan; 22(1):100. PubMed ID: 5420655
    [No Abstract]   [Full Text] [Related]  

  • 33. [Detection of hemagglutination-inhibiting antibodies for rubella virus in a sample of the female adult population of Rome].
    Muzzi A; Rocchi G
    Nuovi Ann Ig Microbiol; 1969; 20(5):448-54. PubMed ID: 5405852
    [No Abstract]   [Full Text] [Related]  

  • 34. Memorandum on the incidence of rubella in Nairobi children as revealed by antibody study.
    Hayden RJ
    East Afr Med J; 1971 Nov; 48(11):658-61. PubMed ID: 5145219
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the behavior of specific hemagglutination-inhibiting antibodies in rubella].
    Monari E; Pezzoli A
    G Mal Infett Parassit; 1971 Mar; 23(5):279-83. PubMed ID: 5113977
    [No Abstract]   [Full Text] [Related]  

  • 36. [Epidemiology of rubella infection: sero-epidemiological findings in a maternal and neonatal population in an interepidemic period].
    Moiraghi Ruggenini A; Simonetta R; Moiraghi C; Zotti C
    G Batteriol Virol Immunol; 1981; 74(1-6):67-76. PubMed ID: 7308627
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel.
    Cohen D; Muhsen Kh; Aboudy Y; Harari H; Mendelson E; Green MS
    Vaccine; 2006 Jul; 24(27-28):5604-8. PubMed ID: 16716460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rubella: contribution to the knowledge of the immune state in the province of Badajoz].
    Gimeno Ortiz A; Jiménez Romano R
    Rev Sanid Hig Publica (Madr); 1983; 57(5-6):499-508. PubMed ID: 6669917
    [No Abstract]   [Full Text] [Related]  

  • 39. [Seroepidemiological survey of 959 persons with rubella in Beijing].
    Lin ZM
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Feb; 4(1):32-3. PubMed ID: 6883474
    [No Abstract]   [Full Text] [Related]  

  • 40. [German measles and cytomegalic virus disease contamination of the female population].
    Falk W; Glawogger F
    Wien Med Wochenschr; 1974 Apr; 124(17):267-71. PubMed ID: 4363465
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.